Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
2025 Banerjee, S; Van Nieuwenhuysen, E; Aghajanian, C; D'Hondt, V; Monk, B; Clamp, A; Prendergast, E; Oaknin, A; Ring, K; Colombo, N; Holloway, R; Rodrigues, M; Chon, H; Gourley, C; Santin, A; Thaker, P; Gennigens, C; Newman, G; Salinas, E; Youssoufian, H; Moore, K; Lustgarten, S; O'Malley, D; Van Gorp, T; Grisham, R
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
2025 Concin, N; Matias-Guiu, X; Cibula, D; Colombo, N; Creutzberg, C; Ledermann, J; Mirza, M; Vergote, I; Abu-Rustum, N; Bosse, T; Chargari, C; Espenel, S; Fagotti, A; Fotopoulou, C; Gatius, S; Gonzalez-Martin, A; Lax, S; Levy, B; Lorusso, D; Macchia, G; Marth, C; Morice, P; Oaknin, A; Raspollini, M; Schwameis, R; Sehouli, J; Sturdza, A; Taylor, A; Westermann, A; Wimberger, P; Planchamp, F; Nout, R
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
2025 Ledermann, J; Oza, A; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Colombo, N; Weberpals, J; Clamp, A; Scambia, G; Leary, A; Holloway, R; Gancedo, M; Fong, P; Goh, J; O'Malley, D; Armstrong, D; Banerjee, S; Garcia-Donas, J; Swisher, E; Lebreton, C; Konecny, G; Mcneish, I; Scott, C; Maloney, L; Goble, S; Lin, K; Coleman, R
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial
2025 Harano, K; Fossati, R; Pardo, B; Galli, F; Hudson, E; Antill, Y; Lee, C; Rabaglio, M; Heitz, F; Kolovetsiou-Kreiner, V; Lai, C; Biagioli, E; Manso, L; Nishio, S; Allan, K; Lee, Y; Uggeri, S; Redondo, A; Nakagawa, S; Au, E; Lombard, J; Gadducci, A; Takehara, K; Baldini, E; Palaia, I; Casanova, C; Ardizzoia, A; Bologna, A; Barretina-Ginesta, M; Colombo, N
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis
2025 Kim, Y; Nishio, S; Kim, S; Hasegawa, K; Dubot, C; Valeria Cáceres, M; Tewari, K; Lorusso, D; Lee, J; Liou, W; Li, K; Tekin, C; Colombo, N; Monk, B
Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer
2025 Randall, L; Xiang, Y; Matsumoto, T; Giannarelli, D; Milla, D; Lopez, K; Acevedo, A; Vizkeleti, J; Salani, R; Nogueira-Rodrigues, A; Mejia, F; Korach, J; Akilli, H; Lee, J; Saevets, V; Samouelian, V; Sehouli, J; Tharavichikul, E; Sukhin, V; Colombo, N; Chang, C; Cueva, J; Lalondrelle, S; Petru, E; Szamreta, E; Nguyen, A; Yamada, K; Li, K; Pignata, S; Lorusso, D
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Matulonis, U; Lorusso, D; Oaknin, A; Pignata, S; Dean, A; Denys, H; Colombo, N; Van Gorp, T; Konner, J; Marin, M; Harter, P; Murphy, C; Wang, J; Noble, E; Esteves, B; Method, M; Coleman, R
Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review
2024 Caruso, G; Bruni, S; Lapresa, M; De Vitis, L; Parma, G; Minicucci, V; Betella, I; Schivardi, G; Peccatori, F; Lazzari, R; Cliby, W; Aletti, G; Zanagnolo, V; Maggioni, A; Colombo, N; Multinu, F
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
2021 Concin, N; Creutzberg, C; Vergote, I; Cibula, D; Mirza, M; Marnitz, S; Ledermann, J; Bosse, T; Chargari, C; Fagotti, A; Fotopoulou, C; Gonzalez-Martin, A; Lax, S; Lorusso, D; Marth, C; Morice, P; Nout, R; O'Donnell, D; Querleu, D; Raspollini, M; Sehouli, J; Sturdza, A; Taylor, A; Westermann, A; Wimberger, P; Colombo, N; Planchamp, F; Matias-Guiu, X
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
2021 Concin, N; Matias-Guiu, X; Vergote, I; Cibula, D; Mirza, M; Marnitz, S; Ledermann, J; Bosse, T; Chargari, C; Fagotti, A; Fotopoulou, C; Martin, A; Lax, S; Lorusso, D; Marth, C; Morice, P; Nout, R; O'Donnell, D; Querleu, D; Raspollini, M; Sehouli, J; Sturdza, A; Taylor, A; Westermann, A; Wimberger, P; Colombo, N; Planchamp, F; Creutzberg, C
Immune checkpoint inhibitors alone or in combination for endometrial mismatch repair-deficient/MSI-high population
2024 Canario, R; Colombo, N; Joly, F
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial
2023 Pujade-Lauraine, E; Selle, F; Scambia, G; Asselain, B; Marme, F; Lindemann, K; Colombo, N; Madry, R; Glasspool, R; Vergote, I; Korach, J; Lheureux, S; Dubot, C; Oaknin, A; Zamagni, C; Heitz, F; Gladieff, L; Rubio-Perez, M; Scollo, P; Blakeley, C; Shaw, B; Ray-Coquard, I; Redondo, A
Quantitative Proteomics and Phosphoproteomics Analysis of Patient-Derived Ovarian Cancer Stem Cells
2025 Franciosa, G; Nieddu, V; Battistini, C; Caffarini, M; Lupia, M; Colombo, N; Fusco, N; Olsen, J; Cavallaro, U
Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study
2025 Valenza, C; Mongillo, M; Visconti, M; Katrini, J; Trapani, D; Boldrini, L; Guidi, L; Farfalla, A; Malengo, D; Caruso, G; Derio, S; Lapresa, M; Parma, G; Biagioli, E; Omodeo Salé, E; Curigliano, G; Colombo, N
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
2025 Oza, A; Lisyanskaya, A; Fedenko, A; De Melo, A; Shparyk, Y; Rakhmatullina, I; Bondarenko, I; Colombo, N; Svintsitskiy, V; Biela, L; Nechaeva, M; Lorusso, D; Scambia, G; Cibula, D; Poka, R; Oaknin, A; Safra, T; Mackowiak-Matejczyk, B; Ma, L; Thomas, D; Lin, K; Mclachlan, K; Goble, S; Kristeleit, R
The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment
2025 De Vitis, L; Schivardi, G; Delfrati, S; Biffi, B; Viscardi, A; Rosanu, M; Ribero, L; Caruso, G; Rappa, A; Marinucci, L; Adorisio, R; Zanagnolo, V; Aletti, G; Barberis, M; Guerini-Rocco, E; Peccatori, F; Urbinati, A; Pino, I; Franchi, D; Betella, I; Colombo, N; Multinu, F
Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study
2025 Vergote, I; Copeland, L; Van Gorp, T; Laenen, A; Scambia, G; Thaker, P; Cibula, D; Colombo, N; Lea, J; Gonzalez-Martin, A; Korach, J; Sehouli, J; Monk, B; Heinzelmann-Schwarz, V; Berger, R; Buscema, J; Lau, S; Madry, R; Denys, H; Pepin, J; Salutari, V; Bagameri, A; Ardizzoia, A; Henry, S; Cecere, S; Hruda, M; Iglesias, D; Manso, L; Shai, A; O'Malley, D
A comprehensive analysis of the Italian school system using harmonised open data via the SchoolDataIT R package
2025 Cefalo, L; Maranzano, P
Editorial for the special issue on New Perspectives in Statistics, Data Science and Econometrics for Agriculture, Land Use and Forestry
2025 Carillo, F; Maranzano, P; Otto, P
Regioni italiane verso regioni europee: i fattori della mancata convergenza
2025 Maranzano, P; Romano, R
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Keyword
- Humans5370
- Female2972
- Male2620
- Middle Aged1884
- Adult1787
- Aged1490
- Italy1186
- COVID-191152
- Animals1033
- Nuclear and High Energy Physics742
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS1336
- PHYSICAL REVIEW LETTERS915
- JOURNAL OF HYPERTENSION792
- PHYSICS LETTERS. SECTION B699
- PHYSICAL REVIEW D571
- THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS528
- SCIENTIFIC REPORTS504
- MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY489
- PLOS ONE461
- ASTRONOMY & ASTROPHYSICS454
Editore
- Springer2392
- Elsevier B.V.2226
- Elsevier2193
- Oxford University Press2189
- Elsevier Ltd2184
- American Physical Society2027
- MDPI1942
- Elsevier BV1733
- Elsevier Inc.1299
- Lippincott Williams and Wilkins1254
Lingua
- eng72121
- ita15321
- fre374
- spa235
- por85
- ger53
- ara23
- rus14
- arc8
- chi8
Settore disciplinare
- MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE62
- M-PED/01 - PEDAGOGIA GENERALE E SOCIALE45
- M-PSI/08 - PSICOLOGIA CLINICA39
- INF/01 - INFORMATICA34
- FIS/05 - ASTRONOMIA E ASTROFISICA33
- GEO/08 - GEOCHIMICA E VULCANOLOGIA27
- ING-INF/05 - SISTEMI DI ELABORAZIONE DELLE INFORMAZIONI26
- IUS/08 - DIRITTO COSTITUZIONALE26
- CHIM/03 - CHIMICA GENERALE ED INORGANICA25
- IUS/01 - DIRITTO PRIVATO25
Tipologia
- 01 - Articolo su rivista87973
- 99 - Altro3
- 03 - Contributo in libro2
- 02 - Intervento a convegno1
Accesso al fulltext
- no fulltext49315
- open22400
- reserved14596
- partially open1594
- embargoed62
- mixed11
Progetto
- -1031
- DIP-ECC-DISAT-2018242
- DIP-ECC-MATER-2018152
- MUSA43
- DIP-ECC-FORMAZIONE-2333
- DIP-ECC-PSICOLOGIA-202323
- SWAB20
- UNIMIB-ARIA Toolkit20
- UNICORN19
- ICSC18